We utilized human leukemia cells to test the dasatinib-DNA Au-NPs in a more complex cellular environment as high BIRC5 mRNA expression and dasatinib-sensitive mutations or kinase dependence frequently occur in both chronic and acute leukemia. This evidence concerns the gene BIRC5 and leukemia.